Navigation Links
Genentech's Winning Streak

The firm's shares shot up 40% this morning after it announced that Avastin, which many analysts consider the most important drug in the company's pipeline, has been found to extend the lives of colon cancer patients.

Late last week, new data and a regulatory decision buttressed the outlook for medicines that Genentech (nyse:
Full article >>> the survival times of colon-cancer patients. Second, the patients lived even longer than researchers had hoped when designing the trial. Third, the only significant side effect to emerge in late-stage trials was high blood pressure. (Gastrointestinal bleeding is still listed as a possible, though uncommon, side effect.)

Those three pieces of information were enough to clear away skeptici......

Full article >>> tory watchdogs.

Genentech's strategy may have been high risk, as some analysts said. But now the company looks poised to reap some big rewards.......

Full article >>>
'"/>

Source:wistechnology.com By Matthew Herper 05/19/03


Related biology technology :

1. Winning and losing in the brain gain game
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the U.S. Food and Drug Administration (FDA) has ... section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual ... with moderate-to-severe acute pain in a medically supervised ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire ... grandfather, “Hire for attitude. Train for skill.” , In keeping with this philosophy, the ... as a salesman. Zamzow is hoping to replicate the practice throughout the company. , ...
Breaking Biology Technology:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):